CaVit D
CaVit D, licence 80005692: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Diavite
- Licence holder
- Teva Canada Limited
- NPN or DIN-HM
- 80005692
- Status
- Active licence
- Licence date
- 5 May 2008
- Revision date
- 20 December 2022
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine D: up to 20 µg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Calcium: up to 1,000 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 800 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine D Source : Cholécalciférol Potency : 400.0 UI | 10.0 mcg | 20 µg |
| Calcium Source : Carbonate de calcium | 500.0 mg | 1,000,000 µg |
Non-medicinal ingredients
Talc, gomme acacia, Béhénate de glycéryle, Dioxyde de titane, FD & C Jaune no. 6, Cellulose, microcristalline, Maltodextrine, Poly(alcool vinylique), Poly(éthylène glycol), Croscarmellose de sodium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 1.0 Comprimé | minimum: 1.0 Tous les jours ; maximum: 2.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Vitamin / Mineral supplement. A factor in the maintenance of good health. Vitamin D helps in the development and maintenance of bones and teeth and in the absorption and use of calcium and phosphorous. Calcium helps in the development and maintenance of bones and teeth. Calcium intake, when combined with sufficient Vitamin D, a healthy diet and regular exercise, may reduce the risk of developing of osteoporosis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80005692
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2022. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.